These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30182662)

  • 1. [Recent Progress in Primary Aldosteronism].
    Shibata H
    Nihon Naika Gakkai Zasshi; 2017 Feb; 106(2):319-26. PubMed ID: 30182662
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
    Amar L; Lorthioir A; Azizi M; Plouin PF
    Eur J Endocrinol; 2015 Mar; 172(3):R125-9. PubMed ID: 25315875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological treatment of primary aldosteronism.
    Janmohamed S; Bouloux PM
    Expert Opin Pharmacother; 2006 Apr; 7(5):563-73. PubMed ID: 16553572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
    Riester A; Reincke M
    Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Hyperaldosteronism: Approach to Diagnosis and Management.
    El-Asmar N; Rajpal A; Arafah BM
    Med Clin North Am; 2021 Nov; 105(6):1065-1080. PubMed ID: 34688415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: are we missing the wood for the trees?
    Funder JW
    Horm Metab Res; 2012 Mar; 44(3):251-3. PubMed ID: 22281545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients.
    Hyla-Klekot L; Kokot F
    Pol Arch Med Wewn; 2013; 123(10):547-51. PubMed ID: 24104388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].
    Maciá-Bobes C; Ronzón-Fernández A; Castaño-Fernández G; Botas-Cervero P
    Aten Primaria; 2006 Feb; 37(2):104-7. PubMed ID: 16527118
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone and Treatment-Resistant Hypertension.
    Leopold JA; Ingelfinger JR
    N Engl J Med; 2023 Feb; 388(5):464-467. PubMed ID: 36724334
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
    Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C
    Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cautions over idiopathic aldosteronism.
    Lim P O; McDonald TM
    Lancet; 2001 Jul; 358(9278):332-3. PubMed ID: 11501536
    [No Abstract]   [Full Text] [Related]  

  • 14. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mineralocorticoid receptor in insulin resistance.
    Garg R; Adler GK
    Curr Opin Endocrinol Diabetes Obes; 2012 Jun; 19(3):168-75. PubMed ID: 22499218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism".
    Monticone S; Veglio F; Mulatero P
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e896-e897. PubMed ID: 34610098
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism".
    Rossi GP; Rossitto G
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e892-e893. PubMed ID: 34610120
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of primary aldosteronism.
    Mulatero P; Monticone S; Veglio F
    Rev Endocr Metab Disord; 2011 Mar; 12(1):3-9. PubMed ID: 21279548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of aldosterone excess.
    Deinum J; Riksen NP; Lenders JW
    Pharmacol Ther; 2015 Oct; 154():120-33. PubMed ID: 26213109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A syndrome resembling primary aldosteronism (Conn syndrome) in untreated HIV disease.
    Stricker RB; Goldberg DA; Hu C; Hsu JW; Goldberg B
    AIDS; 1999 Sep; 13(13):1791-2. PubMed ID: 10509589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.